| MERCK KGAA O.N. | 103.30 / +0.05% |
| Date/Time | 12/10 / 11:30 |
| Chg. / Chg.(%) | 0.05 / +0.05% |
| Bid | 103.10 / 200 |
| Ask | 103.15 / 200 |
| Open | 102.75 |
| Previous Close | 103.25 |
| High | 103.30 |
| Low | 102.60 |
| Volume [EUR] | 0.00 |
| Volume [Units] | 0 |
| Price fixings | 6 |
| ISIN | DE0006599905 |
| Security | MRK |
| Exchange | Düsseldorf |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| London Inter.. | 102.86 |  |
198,893 |
| Xetra | 103.15 | |
134,545 |
| Cboe Europe .. | 103.10 | |
29,898 |
| Cboe Europe .. | 103.15 | |
10,908 |
| Turquoise | 103.10 | |
8,075 |
| TradeGate | 103.200 | |
1,884 |
| Stuttgart | 103.100 | |
710 |
| Frankfurt | 103.2000 | |
589 |
| Vienna Globa.. | 103.00 | |
0 |
| Hamburg | 102.80 |  |
0 |
| Düsseldorf | 103.30 | |
0 |
| München | 103.00 | |
0 |
| Hannover | 102.80 | |
0 |
| Berlin | 102.90 | |
0 |
| Lang & Schwa.. | 103.100 | |
|
| gettex | 103.100 | |
|
| Borsa Italia.. | 103.65 | 78 | |
| Nasdaq Other.. | 113.2000 | |
40 |
| SIX Swiss Ex.. | 102.20 | ||
| SIX Swiss Ex.. | 97.00 | ||
| EUREX | Options | ||
News
- Bioncotech Therapeutics Announces Oncology Clinical Trial Collaboration with MSD
10:00 - GlobeNewswire - Merck to acquire ArQule for $2.7B
12/09/2019 / 23:36 - TeleTrader - Vaccinex Reports Third Quarter 2019 Financial Results and Provides Corporate Update
11/12/2019 / 14:00 - GlobeNewswire - Vaccinex Presents Updated Interim Data from a Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) in Non-Small Cell Lung Cancer at the 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
11/09/2019 / 14:02 - GlobeNewswire - Merck says Q3 sales jump 12% YoY to $12.4B
10/29/2019 / 11:49 - TeleTrader
Real-time